Literature DB >> 3105322

Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.

K Sheibani, C D Winberg, S van de Velde, D W Blayney, H Rappaport.   

Abstract

The authors investigated the distribution of interleukin-2 receptors (TAC antigen) in the lymph nodes of 300 patients with lymphoproliferative disorders. They used fresh-frozen sections to evaluate a possible correlation between the immunophenotype of specific lymphoid disorders and the presence or absence of TAC expression and to determine whether the TAC positivity of lymphoid cells contributes to the characterization of lymphoproliferative processes. All of the cases had previously been studied with a large screening panel of monoclonal antibodies and polyclonal antisera. Among 85 patients with a variety of benign reactive processes, the lymph nodes from 47 contained TAC-bearing lymphocytes in various patterns of distribution. Of 41 patients with Hodgkin's disease, 37 had TAC-bearing lymphocytes. Of 26 B-cell, well-differentiated lymphocytic lymphomas (WDL), 14 were diffusely TAC-positive and one had TAC-bearing cells in random distribution. Six cases of intermediate lymphocytic lymphoma were also studied, and three showed randomly distributed TAC-bearing lymphocytes. Of 19 patients with follicular or follicular and diffuse, poorly differentiated lymphocytic (PDL) lymphoma, 14 were TAC-positive. All 3 diffuse PDL lymphomas studied were TAC-negative. Among 23 cases of B-cell and 5 cases of T-cell mixed cell lymphoma, 15 and three, respectively, had TAC-positive lymphocytes. Of 39 large cell lymphomas (B-cell, 33; T-cell, 6), 14 were TAC-positive. All 13 cases of hairy cell leukemia were diffusely positive. Of 23 T-lymphoblastic lymphomas, only 1 showed positive TAC reactivity, which was focal. Of 5 cases of cutaneous T-cell lymphoma, 2 had TAC-bearing lymphocytes. Our study indicates that the TAC antigen is not lineage-specific, and that it may be expressed by lymphoid cells regardless of their phenotype.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3105322      PMCID: PMC1899594     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

1.  Structural and functional characterization of IL 2 receptors on activated human B cells.

Authors:  A W Boyd; D C Fisher; D A Fox; S F Schlossman; L M Nadler
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

2.  Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody.

Authors:  T Suzuki; M D Cooper
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

3.  In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor.

Authors:  R L Modlin; F M Hofman; D A Horwitz; L A Husmann; S Gillis; C R Taylor; T H Rea
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

4.  Immunohistologic localization and immune phenotypes of lymphocytes expressing Tac antigen in human lymphoid tissues.

Authors:  T Miyawaki; S Ohzeki; N Ikuta; H Seki; K Taga; N Taniguchi
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

5.  Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.

Authors:  S J Korsmeyer; W C Greene; J Cossman; S M Hsu; J P Jensen; L M Neckers; S L Marshall; A Bakhshi; J M Depper; W J Leonard; E S Jaffe; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

6.  Induction of IgG secretion in a human B cell clone with recombinant IL 2.

Authors:  H Kishi; S Inui; A Muraguchi; T Hirano; Y Yamamura; T Kishimoto
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

7.  Modulation of human natural killer cell activity by recombinant human interleukin 2.

Authors:  A R Shaw; R C Bleackley; J P Merryweather; P J Barr
Journal:  Cell Immunol       Date:  1985-02       Impact factor: 4.868

8.  Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease.

Authors:  G Pizzolo; M Chilosi; G Semenzato; F Caligaris-Cappio; L Fiore-Donati; G Perona; G Janossy
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

9.  Expression of interleukin 2 receptors on activated human B cells.

Authors:  T A Waldmann; C K Goldman; R J Robb; J M Depper; W J Leonard; S O Sharrow; K F Bongiovanni; S J Korsmeyer; W C Greene
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

10.  Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.

Authors:  R H Zubler; J W Lowenthal; F Erard; N Hashimoto; R Devos; H R MacDonald
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more
  13 in total

1.  The proliferation rate of T and B lymphocytes in cerebrospinal fluid.

Authors:  R S Thomas; W Beuche; K Felgenhauer
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

2.  Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.

Authors:  Christian M Capitini; Terry J Fry; Crystal L Mackall
Journal:  Am J Immunol       Date:  2009-01-01

3.  Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo.

Authors:  Yuri Kasama; Satoshi Sekiguchi; Makoto Saito; Kousuke Tanaka; Masaaki Satoh; Kazuhiko Kuwahara; Nobuo Sakaguchi; Motohiro Takeya; Yoichi Hiasa; Michinori Kohara; Kyoko Tsukiyama-Kohara
Journal:  Blood       Date:  2010-08-23       Impact factor: 22.113

4.  A comprehensive immunophenotypic marker analysis of hairy cell leukemia in paraffin-embedded bone marrow trephine biopsies--a tissue microarray study.

Authors:  Judit Tóth-Lipták; Klára Piukovics; Zita Borbényi; Judit Demeter; Enikő Bagdi; László Krenács
Journal:  Pathol Oncol Res       Date:  2014-06-06       Impact factor: 3.201

5.  Expression of p55 (Tac) interleukin-2 receptor (IL-2R), but not p75 IL-2R, in cultured H-RS cells and H-RS cells in tissues.

Authors:  S M Hsu; C K Tseng; P L Hsu
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

Review 6.  Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.

Authors:  Cédric Rossi; Marie-Lorraine Chrétien; René-Olivier Casasnovas
Journal:  Target Oncol       Date:  2018-06       Impact factor: 4.493

7.  Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.

Authors:  M E Kadin; B A Agnarsson; L R Ellingsworth; S R Newcom
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

8.  Peripheral T-cell lymphomas. Immunophenotype, lymphokine production, and immunologic functional characteristics of the lymph-node malignant T cells.

Authors:  S Raziuddin; T Malatani; S al-Sedairy; A H al-Saigh
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

Review 9.  Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia.

Authors:  D M Knowles
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

10.  IL-2 mRNA expression in Tac-positive malignant lymphomas.

Authors:  M Peuchmaur; D Emilie; M C Crevon; P Solal-Celigny; M C Maillot; G Lemaigre; P Galanaud
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.